Bronchial Neoplasms Clinical Trials

Completed

Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours

NCT03101839

Conditions: Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Research Site Sarasota, Florida, United States

Research Site Boston, Massachusetts, United States

Research Site Nashville, Tennessee, United States

Research Site London, United Kingdom

View Trial Details

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma

NCT00483509

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

Azienda Ospedaliera Universitaria San Luigi Gonzaga Orbassano, Turin, Italy

Azienda Ospedaliera Universitaria San Martino Genoa, Italy

Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy

View Trial Details

Completed

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

NCT01806675

Conditions: Adenocarcinoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, +123 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

NCT01903993

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States

Genesis Cancer Center Hot Springs, Arkansas, United States

Loma Linda University Medical Center Loma Linda, California, United States

Kaiser Permanente - San Marcos San Marcos, California, United States

View all 65 locations

View Trial Details

Completed

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

NCT01606748

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +12 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

NCT00037817

Conditions: Adenoma, Advanced Esophageal Cancers, Bronchial Neoplasms, +20 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of rSIFN-co in Subjects With Advanced Solid Tumors

NCT02387307

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations: National Cancer Centre Singapore Singapore

View Trial Details

Completed

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

NCT02848872

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Multicentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLC

NCT02730897

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Completed

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

NCT01168973

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sedona, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alhambra, California, United States

View all 231 locations

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Related conditions